Delivery Order 36C24E25D0014-36C24E26N0059
Award Date 3/3/26
Potential Completion Date 3/2/27
Potential Value $74K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Austin, TX 78753, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Veterans Affairs (VA) Headquarters awarded a new delivery order worth $499,447.00 to Natera Inc., a global leader in cell-free DNA testing. This order extends the period of performance for six months under an existing indefinite delivery contract between the VA and Natera valued at up to $6.72 million over two years. The contract is for Natera to provide minimal residual disease testing services, which analyze cell-free DNA biomarkers in patient blood samples to detect...
- The U.S. Department of Veterans Affairs (VA) has awarded a $35,000 firm fixed-price delivery order contract to Natera Inc., a leading biotechnology company, for next-generation sequencing and peripheral blood circulating tumor DNA (ctDNA) testing services in support of cancer research. This contract is not designated as a set-aside. Natera has been a prime contractor for the VA, providing advanced genomic testing and analysis services, including tumor whole exome sequencing, minimal residual...
- This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Natera Inc., a biotechnology company specializing in advanced genetic and molecular diagnostic testing services. The contract, valued at $79,200.00, is for genetic testing services, with a period of performance from June 6, 2025, to June 6, 2026. Natera Inc. has been a prime contractor for the VA, providing comprehensive genomic analysis and testing services, including tumor whole...
- This $92,391 firm-fixed-price delivery order was awarded by the U.S. Department of Veterans Affairs (VA) to Natera Inc., a leading biotechnology company specializing in advanced genomic and molecular diagnostic testing services. The contract is for minimal residual disease testing services, which support the VA's research and patient care initiatives in oncology and precision medicine. Natera has been awarded multiple federal contracts with the VA, including indefinite delivery contracts...
- This is a firm-fixed-price contract awarded by the Department of Veterans Affairs (VA) to Natera Inc., a biotechnology company specializing in advanced genetic and molecular diagnostic testing services. The contract, valued at $328,300.00, is for tumor whole exome sequencing (WES) and peripheral blood circulating tumor DNA (ctDNA) testing services to support a VA-funded research study on 98 esophageal cancer patients. The contract has a one-year base period with four one-year option periods, and...
- The Department of Veterans Affairs (VA) headquarters awarded an indefinite delivery contract to Natera Inc., doing business as Natera, for up to $6.72 million over two years. This contract covers the delivery of minimal residual disease testing services to detect remaining cancer cells in patients after initial treatment, guiding further treatment decisions. An initial delivery order worth $496,460 was issued to fund research and development activities related to this testing through Fiscal Year...
- <p>The Department of Veterans Affairs Headquarters awarded Natera, Inc., doing business as Natera, a $496,460 firm fixed price delivery order to fund Medical Research and Development Technology for Fiscal Year 2024. The prime contractor, Natera, will provide Medical Research and Development Technology services to the Department of Veterans Affairs from their place of performance in Austin, Texas, starting on September 15, 2023 through September 14, 2024.</p>
- This is a firm-fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Personalis, Inc., a genomic sequencing services provider. The contract, valued at $290,710.00, requires Personalis to provide enhanced analysis of clinical and specimen-derived data on all patients seen at VA network hospitals who have a cancer diagnosis. The contract incorporates the ACE CancerPlus test, a 181-gene cancer test, and is part of the VA's genomic...
- This is a delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Foundation Medicine, Inc., a leading provider of genomic profiling and molecular analysis services. The contract, valued at $135,528.64, is for Next Generation Sequencing (NGS) testing services to support the VA's National Precision Oncology Program at the Richard L. Roudebush VA Medical Center. The contract is a Firm Fixed Price Delivery Order issued under a larger Indefinite Delivery Contract (IDC)...
- This federal contract award from the Department of Veterans Affairs (VA) is for Oncology Testing Services, which have been set aside for small businesses. The prime contractor is Personalis, Inc., a genomic sequencing services provider that utilizes its patented ACE technology. The contract has a potential value of $1,071,490.00 and a completion date of May 8, 2020. Personalis has been awarded multiple delivery orders from the VA's Veterans Health Administration and Veterans Integrated Service...